Stratec Stock
Stratec SE
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Germany
- CEO
- Marcus Wolfinger
- Employees
- 1,383
- Market cap
- €287 M
- IPO
- 16/06/2000
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE is a healthcare company operating within the medical devices industry. The company specializes in the development and manufacturing of cutting-edge automation and instrumentation systems for the in-vitro diagnostics and life sciences sectors. Its…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Stratec stock: price history
1D
-2.3%
1W
+3.3%
1M
-5.0%
6M
+19.2%
YTD
+5.3%
1Y
-14.2%
2Y
-40.9%
5Y
-81.3%
10Y
-57.0%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~14% stronger price swings than usual
Ask the agents about Stratec
Stratec stock metrics
P/E
-591.25
P/B
1.21
EV/EBITDA
12.22
RETURN ON EQUITY
1.7%
NET MARGIN
7.0%
DEBT/EQUITY
0.49
DIVIDEND YIELD
2.5%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
62.4%
FLOAT SHARES
7,579,460
AVG. DAILY VOLUME (30D)
12,471
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Stratec stock
What does Stratec do?
Stratec SE is a company in the Healthcare sector, Medical - Devices industry, headquartered in Germany.
The CEO is Marcus Wolfinger, the company employs around 1,383 people.
The IPO was on 16/06/2000; the stock trades on XETRA under the ticker SBS.DE.
When does Stratec report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 14% stronger than usual.
Does Stratec pay a dividend?
Yes. The last dividend was €0.60 per share, ex-date 24/06/2026, paid on 26/06/2026.
The dividend yield is 2.5% (as of 30/06/2026).
Which stocks are comparable to Stratec?
Comparable stocks include Siemens Healthineers, Drägerwerk, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and DexCom.
How can I get Stratec stock analyzed?
Clicking "Analyze stock" lets five strategies assess Stratec against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.